GLP-1 pancreatitis concerns justified

Study results have raised further concerns over a link between pancreatitis and the use of glucagon-like peptide-1 (GLP-1)-based therapies for patients with Type 2 diabetes.

Source: MedWire News - Gastroenterology - February 28, 2013 Category: Gastroenterology Source Type: news